AARD

Aardvark Therapeutics
$6.69
+$0.37 (+5.85%)Jul 27, 2026
0.3PoorMoatMint rating

MoatMint rates Aardvark Therapeutics (AARD) 0.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.6 out of 10.

Key metrics

The numbers that frame AARD today
Market cap
$145.95M
P/E (TTM)
-2.1
EV / FCF
-1.4
ROIC
-99.6%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.35
52wk High
$17.94

AARD stock rating

How AARD scores on quality, value, growth, momentum and financial health
0.3out of 10
Low overallNeutral business, expensive priceTop 97% of ~5,000 US stocks
QualityFair2.6/10
GrowthPoor0.3/10
MomentumPoor1.1/10
ValuePoor0.5/10
Financial HealthPoor1.3/10

Growth

Revenue and earnings trend for AARD
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about AARD
Is Aardvark Therapeutics a good buy?
No. Aardvark Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Aardvark Therapeutics is selling at a very high price.
What is the market capitalization of AARD?
Aardvark Therapeutics's market capitalization is $145.95M.
What is the P/E ratio for AARD stock?
Aardvark Therapeutics's current P/E ratio is -2.1.
What is the 52-week high for AARD stock?
The 52-week high for Aardvark Therapeutics is $17.94. The current close of $6.69 is 62.7% below that high.
What is the 52-week low for AARD stock?
The 52-week low for Aardvark Therapeutics is $3.35. The current close of $6.69 is 99.7% above that low.
Does AARD stock pay dividends?
Aardvark Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AARD?
Aardvark Therapeutics's Debt / Equity ratio is 0.